|
|
||||||||
(Mig) and Chemokine Responsive to
-2 (Crg-2)1



*
Laboratory of Experimental Immunology, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD 21702;
IRSP, Science Applications International Corporation, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD 21702;
Pediatric Oncology Branch, National Institutes of Health, Bethesda, MD;
Greenbaum Cancer Center, University of Maryland Medical School, Baltimore, MD; and
¶ Laboratory of Molecular Immunoregulation, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD 21702
The IFN-
-inducible proteins monokine induced by IFN-
(Mig)
and chemokine responsive to
-2 (Crg-2) can contribute to
IL-12-induced antiangiogenic and leukocyte-recruiting activities, but
the extent to which leukocytes vs parenchymal cells in different organs
contribute to the production of these molecules remains unclear. The
results presented herein show that IFN-
-dependent induction of Mig
and Crg-2 gene expression can occur in many nonlymphoid organs, and
these genes are rapidly induced in purified hepatocytes isolated from
mice treated with IL-2 plus IL-12, or from Hepa 1-6 hepatoma cells
treated in vitro with IFN-
. In addition to depending on IFN-
, the
ability of IL-12 or IL-2/IL-12 to induce Mig and Crg-2 gene expression
in purified hepatocytes also is accompanied by the coordinate
up-regulation of the IFN-
R
and
-chains, in the absence of
IL-12R components. Supernatants of primary hepatocytes obtained from
mice treated in vivo with IL-2/IL-12 or from hepatocytes treated in
vitro with IFN-
contain increased chemotactic activity for enriched
human and mouse CD3+ T cells, as well as mouse
DX5+ NK cells. The hepatocyte-derived chemotactic activity
for mouse T cells but not NK cells was ablated by Abs specific for Mig
and Crg-2. These results suggest that parenchymal cells in some organs
may contribute substantially to initiation and/or amplification of
inflammatory or antitumor responses.
This article has been cited by other articles:
![]() |
B. Jaruga, F. Hong, W.-H. Kim, and B. Gao IFN-{gamma}/STAT1 acts as a proinflammatory signal in T cell-mediated hepatitis via induction of multiple chemokines and adhesion molecules: a critical role of IRF-1 Am J Physiol Gastrointest Liver Physiol, November 1, 2004; 287(5): G1044 - G1052. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Robertson Role of chemokines in the biology of natural killer cells J. Leukoc. Biol., February 1, 2002; 71(2): 173 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kakimi, T. E. Lane, S. Wieland, V. C. Asensio, I. L. Campbell, F. V. Chisari, and L. G. Guidotti Blocking Chemokine Responsive to {gamma}-2/Interferon (IFN)-{gamma} Inducible Protein and Monokine Induced by IFN-{gamma} Activity In Vivo Reduces the Pathogenetic but not the Antiviral Potential of Hepatitis B Virus-specific Cytotoxic T Lymphocytes J. Exp. Med., December 17, 2001; 194(12): 1755 - 1766. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kakimi, T. E. Lane, F. V. Chisari, and L. G. Guidotti Cutting Edge: Inhibition of Hepatitis B Virus Replication by Activated NK T Cells Does Not Require Inflammatory Cell Recruitment to the Liver J. Immunol., December 15, 2001; 167(12): 6701 - 6705. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |